Science & medicine news
-
SWI/SNF complexes “bookmark” cell identity during division
Read about how Scientists at St. Jude determined how the SWI/SNF chromatin remodeling complex helps cancer cells remember how to be cancerous after division.
-
Epigenetic landscape modulates pioneer transcription factor binding
St. Jude scientists are studying how pioneer transcription factors access tightly wound DNA. Learn about how their findings may impact therapeutic development.
-
Capturing transporter structure paves the way for drug development
Learn how St. Jude scientists captured six new structures of the Spns2 transporter, providing insights to aid therapeutic design for cancer and other diseases.
-
St. Jude scientist M. Madan Babu elected to the Royal Society of London
Director of the St. Jude Center of Excellence for Data-Driven Discovery named a fellow of the 360-year-old British scientific organization.
-
St. Jude tool gets more out of multi-omics data
NetBID2 finds hidden drivers by extracting more from multi-omics data. Learn how the computational tool can find druggable targets in cancer and other diseases.
-
Study shines light on impact of environment on neurocognitive outcomes
Find how the neighborhood economic hardship index predicts baseline and long-term outcomes in pediatric brain tumor patients treated with radiation therapy.